Abstract
Get full access to this article
View all access options for this article.
References
1.
Arnaout
R.
et al. SARS-CoV2 testing: the limit of detection matters . Preprint at bioRxiv . https://doi.org/10.1101/2020.06.02.131144 (2020 ).
2.FDA Reference Panel Comparative Data . Oct. 2 , 2020 .
3.COVID-19 Genomics UK Consortium . COG-UK update on SARS-CoV-2 Spike mutations of special interest: Report 1 (December 19, 2020) . https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf
4.European Center for Disease Prevention and Control (2020 ) Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom . https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-rapid-increase-sars-cov-2-variant-united-kingdom
5.
Rambaut
A.
, et al. (Dec 20 , 2020 ) Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations: COVID-19 genomics UK consortium . https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-inthe-uk-defined-by-a-novel-set-of-spike-mutations/563